Fairmount Funds Management LLC sold ORKA
July 1, 2026 · Form 4 insider transaction
Fairmount Funds Management LLC sold 3,553,410 shares of Oruka Therapeutics, Inc. at $84.43 per share, a transaction worth $300.01M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,553,410
Price
$84.43
Total value
$300.01M
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 1, 2026
Filing dateJuly 1, 2026
Shares owned after1,131,954
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fairmount Healthcare Fund II L.P. and Fairmount Healthcare Co-Invest III L.P. The managers of Fairmount are Peter Harwin and Tomas Kiselak. Fairmount, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.